Charles River Laboratories adds Gina Wilson to its Board of Directors

– USA, MA –  Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of Virginia M. Wilson to its Board of Directors. She is the recently retired Senior EVP and CFO of Teachers Insurance and Annuity Association of America. Ms. Wilson’s extensive financial management experience across multiple industries will enhance the strategic and financial advisory expertise of Charles River’s Board of Directors.

As a member of the Board, she will serve on the Audit Committee and the Corporate Governance and Nominating Committee.

“Gina Wilson’s diverse experience across multiple industries will enhance the financial acumen and oversight of Charles River’s Board, in support of our broader strategy and focus on driving profitable growth,” said James C. Foster, Chairman, President and CEO Charles River.

“Ms. Wilson brings highly valuable knowledge and experience in managing the Finance organizations of growing businesses, strategically allocating capital, and driving operating efficiency that will complement the combined skills and experience of our current directors. She will also help ensure the continuing success of the Corporate Governance and Nominating Committee’s commitment to developing the diversity of skills, experience, and perspectives the Board will need to successfully guide our global organization. We look forward to working with Gina and her contributions to the continued, long-term success of Charles River.” he added.

About Gina Wilson

Ms. Wilson has more than 30 years of financial management experience overseeing the accounting, actuarial, tax, and financial planning and reporting functions at large, multinational organizations. Prior to retiring in March 2019, she was Senior Executive Vice President and Chief Financial Officer of TIAA, where she was responsible for leading the Fortune 100 company’s finance and actuarial functions, as well as overseeing its insurance company general account, corporate real estate, and sourcing. Prior to joining TIAA in 2010, Ms. Wilson served as Executive Vice President and Chief Financial Officer of Wyndham Worldwide Corporation, leading Wyndham’s finance and technology organizations following its spin-off from Cendant Corporation in 2006. Previously, she served as Cendant’s Executive Vice President and Chief Accounting Officer and also served as Senior Vice President and Corporate Controller of both MetLife, Inc. and Transamerica’s life insurance division. Ms. Wilson began her career at Deloitte and is a Certified Public Accountant. She is a Board member of Conduent Incorporated and Trustee and Vice-Chair of Catholic Charities of the Archdiocese of New York.

“I am pleased to join Charles River’s Board of Directors and look forward to contributing to the future success and growth of this recognized global leader in early-stage drug research,” said Ms. Wilson. “I am excited to bring my background in finance and capital markets to an organization that is helping to create healthier lives, and I look forward to collaborating with the outstanding team at Charles River.”

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

For more information: https://www.criver.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.